CMIC CMO USA is a contract pharmaceutical company which offers solid dosage form development and manufacturing services, specializing in controlled release. From the early phase of product development to the commercial manufacture of pharmaceutical products, CMIC (pronounced si-mik) utilizes state-of-the-art technologies, contract pharmaceutical experience and emphasis on customer service to meet your strategic needs. A member of the CMIC Group, a full service contract pharmaceutical company, with over 4500 employees in 17 companies (including CMIC HOLDINGS Co., Ltd.) in 30 offices and plants, and 8 countries globally. CMIC is the largest CRO and 2nd largest CMO in Japan. As of Sept. 13, 2013, CMIC CMO USA Corporation is under new executive management.